(Reuters) – Ocugen Inc said on Monday the COVID-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goal of a trial in the United States.
(Reporting by Leroy Leo in Bengaluru; Editing by Savio D’Souza)
Ocugen-Bharat Biotech COVID vaccine meets main goal in trial
Jan 9, 2023 | 5:19 AM
